Literature DB >> 16374338

Screening existing drugs for neurodegeneration: The National Institute of Neurologic Disorders and Stroke (NINDS) model.

Jill Heemskerk1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16374338     DOI： 10.1097/00006982-200512001-00025

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  5 in total

1.  New considerations in the design of clinical trials for amyotrophic lateral sclerosis.

Authors:  James D Berry; Merit E Cudkowicz
Journal:  Clin Investig (Lond)       Date:  2011-10

2.  The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics.

Authors:  Ruili Huang; Noel Southall; Yuhong Wang; Adam Yasgar; Paul Shinn; Ajit Jadhav; Dac-Trung Nguyen; Christopher P Austin
Journal:  Sci Transl Med       Date:  2011-04-27       Impact factor: 17.956

3.  An open source based high content screening method for cell biology laboratories investigating cell spreading and adhesion.

Authors:  Andre Schmandke; Antonio Schmandke; Maurianne A Pietro; Martin E Schwab
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

4.  A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions.

Authors:  Robert Kraft; Allon Kahn; José L Medina-Franco; Mikayla L Orlowski; Cayla Baynes; Fabian López-Vallejo; Kobus Barnard; Gerald M Maggiora; Linda L Restifo
Journal:  Dis Model Mech       Date:  2012-08-23       Impact factor: 5.758

5.  Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone.

Authors:  Elena Ratti; James D Berry; David J Greenblatt; Lorena Loci; Amy Swartz Ellrodt; Jeremy M Shefner; Merit E Cudkowicz
Journal:  Toxicol Rep       Date:  2015
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.